US 12072338
Pharmaceutical peptides for the treatment of inflammatory diseases
granted A61KA61K38/00A61P
Quick answer
US patent 12072338 (Pharmaceutical peptides for the treatment of inflammatory diseases) held by PROTAGONISTS LTD. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PROTAGONISTS LTD.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61P, A61P19/02